Catheter ablation of atrial fibrillation in Korea: results from the Korean Heart Rhythm Society Ablation Registry for Atrial Fibrillation (KARA)
-
Published:2021-10-20
Issue:1
Volume:22
Page:
-
ISSN:2466-1171
-
Container-title:International Journal of Arrhythmia
-
language:en
-
Short-container-title:Int J Arrhythm
Author:
Lee Euijae, Park Hyoung-Seob, Han Seongwook, Nam Gi-Byung, Choi Jong-Il, Pak Hui-Nam, Oh Il-Young, Shin Dong-Gu, On Young Keun, Park Sang Weon, Kim Young-Hoon, Oh SeilORCID, Ahn Jinhee, Ahn Min-Soo, Baek Yong-Soo, Cha Myung-Jin, Cha Tae-Joon, Choi Eue-Keun, Choi Hyung-Oh, Choi Jong-Il, Chun Kwang Jin, Gwag Hye Bin, Han Seongwook, Hwang Youmi, Hyun Dae Woo, Jin Eun-Sun, Kang Ki-Woon, Kim Dae-Hyeok, Kim Dae-Kyung, Kim Dongmin, Kim Ji-Hoon, Kim Jin-Bae, Kim Minsu, Kim Sung-Hwan, Kim Yoo Ri, Kim Young-Hoon, Ko Jum-Suk, Kwak Jae-Jin, Lee Euijae, Lee Sanghee, Lee So-Ryoung, Lee Sung Ho, Lee Young Soo, Nam Gi-Byung, Namgung Jun, Oh Il-Young, Oh SeilORCID, Oh Yong-Seog, On Young Keun, Pak Hui-Nam, Park Hwan-Cheol, Park Hyoung-Seob, Park Hyung Wook, Park Sang Weon, Park Ye Min, Park Young-Ah, Rhee Kyoung-Suk, Shim Jaemin, Shin Dong-Gu, Song In-Geol, Sung Jung-Hoon, Yang Pil-Sung,
Abstract
Abstract
Background
This study aims to investigate the current status of AF (atrial fibrillation) catheter ablation in Korea.
Methods
The patients who underwent AF catheter ablation from September 2017 to December 2019 were prospectively enrolled from 37 arrhythmia centers. Demographic data, procedural characteristics, the extent of catheter ablation, acute success of the ablation lesion set, rate and independent risk factor for recurrence of AF were analyzed.
Results
A total of 2402 AF patients [paroxysmal AF (PAF) 45.7%, persistent AF (PeAF) 43.1% and redo AF 11.2%] were included. Pulmonary vein isolation (PVI) was performed in 2378 patients (99%) and acute success rate was 97.9%. Additional non-PV ablation (NPVA) were performed in 1648 patients (68.6%). Post-procedural complication rate was 2.2%. One-year AF-free survival rate was 78.6% and the PeAF patients showed poorer survival rate than the ones with other types (PeAF 72.4%, PAF 84.2%, redo AF 80.0%). Additional NPVA did not influence the recurrence of AF in the PAF patients (PVI 17.0% vs. NPVA 14.6%, P value 0.302). However, it showed lower AF recurrence rate in the PeAF patients (PVI 34.9% vs. NPVA 24.4%, P value 0.001). Valvular heart disease, left atrial diameter, PeAF, PVI alone, need of NPVA for terminating AF, and failed ablation were independent predictors of AF recurrence.
Conclusions
Additional NPVA was associated better rhythm outcome in the patients with PeAF, not in the ones with PAF. The independent risk factors for AF recurrence in Korean population were similar to previous studies. Further research is needed to discover optimal AF ablation strategy.
Funder
korean heart rhythm society
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Lee SR, Choi EK, Han KD, Cha MJ, Oh S. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population. Int J Cardiol. 2017;236:226–31. 2. Lee H, Kim TH, Baek YS, Uhm JS, Pak HN, Lee MH, et al. The trends of atrial fibrillation-related hospital visit and cost, treatment pattern and mortality in Korea: 10-year nationwide sample cohort data. Korean Circ J. 2017;47(1):56–64. 3. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498. 4. Raatikainen MJ, Hakalahti A, Uusimaa P, Nielsen JC, Johannessen A, Hindricks G, et al. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: on-treatment analysis of the randomized controlled MANTRA-PAF trial. Int J Cardiol. 2015;198:108–14. 5. Blomstrom-Lundqvist C, Gizurarson S, Schwieler J, Jensen SM, Bergfeldt L, Kenneback G, et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial. JAMA. 2019;321(11):1059–68.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|